All News

    FDA Accepts NDA For Dordaviprone in H3 K27M-Mutant Diffuse Glioma

    February 25th 2025, 10:00pm

    Article

    A New Drug Application has been accepted seeking accelerated approval for dordaviprone for patients with recurrent H3 K27M-mutant diffuse glioma, with a target action date of Aug. 18.

    FDA Accepts Priority Review for Pre- and Postsurgical Keytruda in HNSCC

    February 25th 2025, 8:00pm

    Article

    The FDA accepted for priority review a supplemental Biologics License Application for Keytruda for resectable locally advanced head and neck cancer.

    Treating Lymphedema with a Simple Trinket

    February 25th 2025, 6:00pm

    Article

    Buying a pretty bracelet was healing because it let me look at my lymphedema in a new light.

    Understanding Biliary Tract Cancer and The Current Standard of Care

    February 25th 2025, 5:00pm

    Video

    An expert explains what biliary tract cancers are and the current landscape of treatment as well as future advancements.

    Some KRAS Mutations Associated With Worse Outcomes in Pancreatic Cancer

    February 25th 2025, 4:00pm

    Article

    In patients with pancreatic ductal adenocarcinoma, KRAS G12D and G12V mutations hare associated with worse patient outcomes, researchers have found.

    Neoadjuvant Opdivo Combo Elicits Statistically Significant OS Findings in Resectable NSCLC

    February 25th 2025, 2:00pm

    Article

    Neoadjuvant Opdivo with platinum-doublet chemo had a statistically significant and clinically meaningful improvement versus chemo alone in resectable NSCLC.

    What Patients With Cancer Should Know About DPD Deficiency Prior to Chemo

    February 24th 2025, 10:00pm

    Video

    Dr. Gabriel A. Brooks discusses what DPD deficiency is and why it is important for patients with cancer receiving 5-FU or Xeloda to be aware of it.

    FDA Grants Fast Track Designation to AUTX-703 In R/R AML

    February 24th 2025, 8:00pm

    Article

    The Food and Drug Administration granted fast track designation to AUTX-703 for relapsed or refractory acute myelogenous leukemia.

    Colorectal Cancer or Any Type of Cancer Can Test a Friendship

    February 24th 2025, 6:00pm

    Article

    Cancer tested my friendships by showing who could stay present through tough conversations, support me emotionally and endure pain together despite the loss.

    GAP Triplet May Be Less Safe Than Doublet Chemo in Biliary Tract Cancer

    February 24th 2025, 5:00pm

    Video

    An expert explains that the GAP regimen did not improve overall survival in advanced biliary tract cancer versus the doublet and increased severe side effects.